Literature DB >> 7452248

The gamma-aminobutyrate content of nerve endings (synaptosomes) in mice after the intramuscular injection of gamma-aminobutyrate-elevating agents: a possible role in anticonvulsant activity.

J D Wood, M P Russell, E Kurylo.   

Abstract

The intramuscular administration of L-cycloserine, gabaculine, and aminooxyacetic acid caused significant, time-dependent increases in the gamma-aminobutyric acid (GABA) content of both whole brain and synaptosomal-enriched preparations obtained from the tissue, a linear relationship being observed between the two parameters. In contrast, the administration of hydrazine resulted in a large increase in whole brain GABA level, with little change in the synaptosomal GABA content. The key factor in these different responses appeared to be the degree of inhibition of glutamic acid decarboxylase by the drugs. Pretreatment of mice with the GABA-elevating agents resulted in a delay in the onset of seizures, which was related directly to the increase in synaptosomal GABA content. Although the seizures were delayed, they occurred while the GABA content of nerve endings (synaptosomes) was above that in preparations from untreated animals. The decrease in GABA content at the onset of seizures, expressed as a percentage of the level at the time of injection of the convulsant agent, was, however, reasonably constant. A hypothesis to explain these results is proposed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7452248     DOI: 10.1111/j.1471-4159.1980.tb12497.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Regulation of the GABAA receptor/ion channel complex by intracellular GABA levels.

Authors:  J D Wood; M Davies
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

Review 2.  Glutamate, GABA, and CNS disease: a review.

Authors:  J E Walker
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

3.  Convulsions and inhibition of glutamate decarboxylase by pyridoxal phosphate-gamma-glutamyl hydrazone in the developing rat.

Authors:  L Massieu; A Rivera; R Tapia
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

4.  Accumulation of labeled gamma-aminobutyric acid into rat brain and brain synaptosomes after i.p. injection.

Authors:  L Vignolo; A Cupello; P Mainardi; M V Rapallino; A Patrone; C Loeb
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

5.  Inhibition of the rate of GABA synthesis in regions of rat brain following a convulsion.

Authors:  A R Green; A Metz; M C Minchin; N D Vincent
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

6.  Alterations in synaptosomal neurotransmitter amino acids in "petit-mal" rats at a daytime and a nighttime.

Authors:  S Simler; L Ciesielski; S Gobaille; P Mandel
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

7.  Evaluation of the mechanisms by which gamma-amino-butyric acid in association with phosphatidylserine exerts an antiepileptic effect in the rat.

Authors:  E Benassi; G Besio; A Cupello; P Mainardi; A Patrone; M V Rapallino; L Vignolo; C W Loeb
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

8.  On the existence of two GABA pools associated with newly synthesized GABA and with newly taken up GABA in nerve terminals.

Authors:  M Abe; M Matsuda
Journal:  Neurochem Res       Date:  1983-05       Impact factor: 3.996

9.  Amplification by glycine of the effect of the GABA transport inhibitor THPO on synaptosomal GABA level.

Authors:  J D Wood; P Krogsgaard-Larsen; A Schousboe
Journal:  Neurochem Res       Date:  1988-10       Impact factor: 3.996

10.  Synergistic anticonvulsant effects of GABA-T inhibitors and glycine.

Authors:  N Seiler; S Sarhan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.